The combination of
azlocillin and
gentamicin or
tobramycin, in the treatment of lower
respiratory tract infection due to Pseudomonas aeruginosa in patients with
cystic fibrosis, was evaluated. Twenty patients, 10 boys and 10 girls (mean age 13 1/2 years) who had lower
respiratory tract infection with positive sputum culture for P. aeruginosa, were given
azlocillin i.v. 20 mg/kg every 8 hours for 10 to 12 days. In addition, either
gentamicin, 2.5 to 4 mg/kg i.v. every 12 hours, or
tobramycin, 4 to 5 mg/kg i.v. every 8 hours, was given. The
antibiotics were given in short-term infusions (20 minutes). Besides the
antibiotic treatment, the patients received
inhalation therapy, pulmonary physiotherapy, and pancreatic
enzymes. Pharmacokinetic studies showed that
azlocillin concentrations in serum were within therapeutic levels, and in sputum they inhibited 75% of all P. aeruginosa strains. However, in only 12 of the 52 treatment courses was Pseudomonas eliminated from the sputum.